COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature

BACKGROUND: It is reasonable to think that cancer patients undergoing chemotherapy, targeted therapy or immunotherapy could have a more aggressive course if positive for Coronavirus disease CoV-2 (COVID- 19). METHODS: We conducted a literature review on https://www.ncbi.nlm.nih.gov/pubmed/, https://...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lorenzo, Giuseppe, Di Trolio, Rossella, Kozlakidis, Zisis, Busto, Giuseppina, Ingenito, Concetta, Buonerba, Luciana, Ferrara, Claudia, Libroia, Annamaria, Ragone, Gianluca, Ioio, Concetta dello, Savastano, Beatrice, Polverino, Mario, De Falco, Ferdinando, Iaccarino, Simona, Leo, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239789/
https://www.ncbi.nlm.nih.gov/pubmed/32544802
http://dx.doi.org/10.1016/j.critrevonc.2020.102991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239789/
https://www.ncbi.nlm.nih.gov/pubmed/32544802
http://dx.doi.org/10.1016/j.critrevonc.2020.102991

Ejemplares similares